TABLE 2.
Follow-up of patients with coronary artery restenosis.
| Total (n = 1,793) | Diabetic patients (n = 795) | Non-diabetic patients (n = 998) | P-value | |
| Time of follow-up (years,± s) | 2.96 ± 0.56 | 2.96 ± 0.56 | 2.95 ± 0.55 | 0.7608 |
| MACE, n (%) | 137 (7.64) | 54 (6.79) | 83 (8.32) | 0.2275 |
| Cardiac death, n (%) | 26 (1.45) | 6 (0.75) | 20 (2.00) | 0.0279 |
| Non-fatal MI, n (%) | 12 (0.67) | 4 (0.50) | 8 (0.80) | 0.4413 |
| TLR, n (%) | 85 (4.74) | 33 (4.15) | 52 (5.21) | 0.2943 |
| Stroke, n (%) | 18 (1.00) | 13 (1.64) | 5 (0.50) | 0.0167 |
| Secondary endpoints, n (%) | 141 (7.86) | 53 (6.67) | 88 (8.82) | 0.0928 |
| All-cause death, n (%) | 42 (2.34) | 15 (1.89) | 27 (2.71) | 0.2549 |
| TVR, n (%) | 82 (4.57) | 32 (4.03) | 50 (5.01) | 0.3213 |
| ST*, n (%) | 7 (0.39) | 1 (0.13) | 6 (0.60) | 0.1411 |
| Hemorrhage, n (%) | 21 (1.17) | 8 (1.01) | 13 (1.30) | 0.5623 |
*All presented with probable stent thrombosis.